OBJECTIVES: To perform a critical review of the literature on the mood and cognitive changes associated with subclinical hypothyroidism (SCH), with an emphasis on older adults. To evaluate these data against the Consensus Statement on the management of SCH from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. METHOD: A comprehensive literature review. RESULTS: Subclinical hypothyroidism may be associated with an increased risk of mood and cognitive dysfunction, although the strength of this association and the efficacy of replacement hormone therapy require further investigation. CONCLUSION: It remains unclear whether SCH leads to significant mood and cognitive impairments in most older patients. More research is required to determine the nature and extent of this association and whether thyroid hormone replacement therapy is appropriate and effective in treating SCH-associated neurobehavioral impairments.
OBJECTIVES: To perform a critical review of the literature on the mood and cognitive changes associated with subclinical hypothyroidism (SCH), with an emphasis on older adults. To evaluate these data against the Consensus Statement on the management of SCH from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. METHOD: A comprehensive literature review. RESULTS:Subclinical hypothyroidism may be associated with an increased risk of mood and cognitive dysfunction, although the strength of this association and the efficacy of replacement hormone therapy require further investigation. CONCLUSION: It remains unclear whether SCH leads to significant mood and cognitive impairments in most older patients. More research is required to determine the nature and extent of this association and whether thyroid hormone replacement therapy is appropriate and effective in treating SCH-associated neurobehavioral impairments.
Authors: J Parle; L Roberts; S Wilson; H Pattison; A Roalfe; M S Haque; C Heath; M Sheppard; J Franklyn; F D R Hobbs Journal: J Clin Endocrinol Metab Date: 2010-05-25 Impact factor: 5.958
Authors: M P Vanderpump; W M Tunbridge; J M French; D Appleton; D Bates; F Clark; J Grimley Evans; D M Hasan; H Rodgers; F Tunbridge Journal: Clin Endocrinol (Oxf) Date: 1995-07 Impact factor: 3.478
Authors: Mary H Samuels; Rajani Kaimal; Avantika Waring; Howard A Fink; Kristine Yaffe; Andrew R Hoffman; Eric Orwoll; Douglas Bauer Journal: Thyroid Date: 2016-09 Impact factor: 6.568
Authors: May A Beydoun; Hind A Beydoun; Ola S Rostant; Greg A Dore; Marie T Fanelli-Kuczmarski; Michele K Evans; Alan B Zonderman Journal: Neurobiol Aging Date: 2015-08-08 Impact factor: 4.673
Authors: Simon H S Pearce; Georg Brabant; Leonidas H Duntas; Fabio Monzani; Robin P Peeters; Salman Razvi; Jean-Louis Wemeau Journal: Eur Thyroid J Date: 2013-11-27
Authors: Silvana Oliveira E Silva; I Thien Chan; Maryna A Lobo Santos; Marcela Cohen; Mayra de La Roque P Araujo; Julia da Silva Almeida; Andressa Simões; Helder Renato B Givigi; Mario Vaisman; Carlos M Paixão; Patricia de Fatima Dos S Teixeira Journal: Endocrine Date: 2013-11-01 Impact factor: 3.633
Authors: Abimbola A Akintola; Steffy W Jansen; David van Bodegom; Jeroen van der Grond; Rudi G Westendorp; Anton J M de Craen; Diana van Heemst Journal: Front Aging Neurosci Date: 2015-08-11 Impact factor: 5.750